Single nucleotide polymorphism (SNP) targeting therapies for the treatment of huntington'S disease
US-8987222-B2 · Mar 24, 2015 · US
US10428019B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10428019-B2 |
| Application number | US-201113825627-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 22, 2011 |
| Priority date | Sep 24, 2010 |
| Publication date | Oct 1, 2019 |
| Grant date | Oct 1, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosed and claimed compounds are chiral auxiliaries useful for efficiently producing a phosphorus atom-modified nucleic acid derivative with high stereoregularity. The disclosed and claimed compounds include those represented by the following formula (I) or formula (XI) for introducing the chiral auxiliaries.
Opening claim text (preview).
What is claimed is: 1. A nucleic acid derivative comprising a chiral auxiliary, wherein the chiral auxiliary is represented by formula (II) and binds to a phosphorus atom of a phosphite moiety of the nucleic acid derivative through the oxygen atom of the chiral auxiliary, wherein the squiggly line represents the point of attachment to a phosphorus atom of a phosphite moiety of the nucleic acid derivative: in which R 1 and R 2 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group; R 3 represents an unsubstituted or substituted aryl group or an unsubstituted or substituted alkyl group; R 4 and R 5 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group; Y represents -Y 1 -Y 2 -, where Y 1 represents —C(R 6 )(R 7 )— in which R 6 and R 7 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group, or Y 1 represents an unsubstituted or substituted o-aryldiyl group, and Y 2 represents a single bond or —C(R 8 )(R 9 )— in which R 8 and R 9 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group. 2. The nucleic acid derivative of claim 1 , wherein R 3 represents an unsubstituted or substituted aryl group. 3. The nucleic acid derivative of claim 2 , wherein Y 2 represents a single bond. 4. The nucleic acid derivative of claim 1 , wherein Y 1 represents an unsubstituted or substituted o-aryldiyl group. 5. A nucleoside-3′-phosphoramidite reagent represented by formula (IV): in which R 1 and R 2 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group; R 3 represents an unsubstituted or substituted aryl group or an unsubstituted or substituted alkyl group; R 4 and R 5 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group; Y represents -Y 1 -Y 2 -, where Y 1 represents —C(R 6 )(R 7 )— in which R 6 and R 7 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group, or Y 1 represents an unsubstituted or substituted o-aryldiyl group, and Y 2 represents a single bond or —C(R 8 )(R 9 )— in which R 8 and R 9 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group; R 21 represents a protective group of a hydroxyl group; R 22 represents a hydrogen atom, an alkoxy group, a fluorine atom, or a protected hydroxyl group; and Bs represents a nucleobase. 6. The reagent of claim 5 , wherein R 3 represents an unsubstituted or substituted aryl group. 7. The reagent of claim 5 , wherein Y 1 represents an unsubstituted or substituted o-aryldiyl group. 8. The reagent of claim 7 , wherein Y 2 represents a single bond. 9. A compound represented by formula (XI), or a salt thereof: in which R 101 and R 102 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group; R 103 represents a cyano group, a halogen atom, a halogenated unsubstituted or substituted alkyl group, a substituted or unsubstituted halogenated alkanoyl group, a C 1 -C 6 alkylsulfonyl group, a substituted or unsubstituted halogenated alkylsulfonyl group, or a nitro group; Z represents -Z 1 -Z 2 -, in which Z 1 represents —C(R 104 )(R 105 )— wherein R 104 and R 105 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group, and Z 2 represents a single bond or —C(R 106 )(R 107 )— wherein R 106 and R 107 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group. 10. The compound or a salt thereof according to claim 9 , wherein R 101 and R 102 are independently a hydrogen atom or an unsubstituted or substituted alkyl group, R 103 is a cyano group, and Z is —C(R 104 )(R 105 )— wherein R 104 and R 105 are independently a hydrogen atom or an unsubstituted or substituted alkyl group. 11. The compound or a salt thereof of claim 9 , wherein R 101 and R 102 are hydrogen atoms, R 103 is a cyano group, and Z is —C(R 106 )(R 105 )— wherein R 104 and R 105 are hydrogen atoms. 12. The compound or a salt thereof of claim 9 , wherein R 103 is a cyano group. 13. A nucleic acid derivative, wherein a chiral auxiliary represented by the following general formula (XII) binds to a phosphorus atom of a phosphite moiety of the nucleic acid derivative through the oxygen of the chiral auxiliary, wherein the squiggly line represents the point of attachment to a phosphorus atom of a phosphite moiety of the nucleic acid derivative: in which R 101 and R 102 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substit
Processes for the preparation of sugar derivatives · CPC title
attached in position 4 · CPC title
with ribosyl as saccharide radical · CPC title
Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title
Oxygen atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.